Related Experiment Video
Updated: Feb 9, 2026

Forward Genetic Screen Using Transgenic Calcium Reporter Aequorin to Identify Novel Targets in Calcium Signaling
Published on: August 1, 2020
Calcium signaling and the therapeutic targeting of cancer cells
Alice H L Bong1, Gregory R Monteith2
1The School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.
Abstract:
The calcium signal is implicated in a variety of processes important in tumor progression (e.g. proliferation and invasiveness). The calcium signal has also been shown to be important in other processes important in cancer progression including the development of resistance to current cancer therapies. In this review, we discuss how Ca2+ channels, pumps and exchangers may be drug targets in some cancer types. We consider what factors should be taken into account when considering an optimal Ca2+ channel, pump or exchanger as a candidate for further assessment as a novel drug target in cancer. We also present and summarize how some therapies for the treatment of cancer intersect with Ca2+ signaling and how pharmacological manipulation of the machinery of Ca2+ signaling could promote the effectiveness of some therapies. We also review new therapeutic opportunities for Ca2+ signal modulators in the context of the tumor microenvironment.
Insights
Altering calcium (Ca2+) signaling pathways presents a promising strategy for cancer treatment. Targeting calcium channels, pumps, and exchangers could enhance current cancer therapies and overcome drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Calcium (Ca2+) signaling is crucial for tumor progression, influencing proliferation and invasiveness.
- Calcium signaling also plays a role in the development of resistance to cancer therapies.
Purpose of the Study:
- To review calcium (Ca2+) channels, pumps, and exchangers as potential drug targets in cancer.
- To discuss factors for selecting optimal Ca2+ signaling targets for novel cancer drug development.
- To explore the intersection of current cancer therapies with Ca2+ signaling and the potential for pharmacological modulation.
Main Methods:
- Literature review of Ca2+ signaling in cancer progression.
- Analysis of Ca2+ channels, pumps, and exchangers as drug targets.
- Examination of Ca2+ signaling's role in therapy resistance and response.
- Review of therapeutic opportunities involving Ca2+ signal modulators.
Main Results:
- Ca2+ channels, pumps, and exchangers represent viable drug targets for specific cancer types.
- Optimizing Ca2+ signaling targets requires careful consideration of various factors for drug development.
- Pharmacological manipulation of Ca2+ signaling can potentially enhance the efficacy of existing cancer treatments.
- The tumor microenvironment offers new therapeutic avenues for Ca2+ signal modulators.
Conclusions:
- Targeting calcium (Ca2+) signaling machinery offers a novel approach to cancer therapy.
- Modulating Ca2+ signaling can potentially overcome drug resistance and improve treatment outcomes.
- Further research into Ca2+ signal modulators holds promise for developing new cancer drugs.
More Related Videos
Related Concept Videos
What is Cell Signaling?
Cell-surface Signaling
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Endocrine Signaling
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...

